Tag: ridgeline therapeutics
-

Ridgeline Therapeutics Cuts Staff After Clinical Trial Setback
Ridgeline Therapeutics is cutting 45 jobs after its lead drug candidate failed a mid-stage clinical trial, a setback that tempers Foundry Row’s steady biotech growth narrative.
-

Ridgeline Therapeutics Raises Its Own Funding Round Amid Talent Competition With Kestrel
Ridgeline Therapeutics has closed a $38 million funding round it says is aimed at competing with rival Kestrel Biologics for Bellwater’s limited pool of biotech talent.